» Articles » PMID: 24375134

The Sialidases of Clostridium Perfringens Type D Strain CN3718 Differ in Their Properties and Sensitivities to Inhibitors

Overview
Date 2013 Dec 31
PMID 24375134
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium perfringens causes histotoxic infections and diseases originating in animal or human intestines. A prolific toxin producer, this bacterium also produces numerous enzymes, including sialidases, that may facilitate infection. C. perfringens type D strain CN3718 carries genes encoding three sialidases, including two large secreted sialidases (named NanI and NanJ) and one small sialidase (named NanH) that has an intracellular location in log-phase cultures but is present in supernatants of death phase cultures. Using isogenic mutants of CN3718 that are capable of expressing only NanJ, NanI, or NanH, the current study characterized the properties and activities of each sialidase. The optimal temperature determined for NanJ or NanH enzymatic activity was 37°C or 43°C, respectively, while NanI activity increased until temperature reached 48°C. NanI activity was also the most resistant against higher temperatures. All three sialidases showed optimal activities at pH 5.5. Compared to NanJ or NanH, NanI contributed most to the sialidase activity in CN3718 culture supernatants, regardless of the substrate sialic acid linkage; NanI also released the most sialic acid from Caco-2 cells. Only NanI activity was enhanced by trypsin pretreatment and then only for substrates with an α-2,3- or α-2,6-sialic acid linkage. NanJ and NanI activities were more sensitive than NanH activity to two sialidase inhibitors (N-acetyl-2,3-dehydro-2-deoxyneuraminic acid and siastatin B). The activities of the three sialidases were affected differently by several metal ions. These results indicated that each C. perfringens sialidase has distinct properties, which may allow these enzymes to play different roles depending upon environmental conditions.

Citing Articles

Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines.

Siwak K, LeBlanc E, Scott H, Kim Y, Pellizzari-Delano I, Ball A PLoS Pathog. 2024; 20(12):e1012365.

PMID: 39625989 PMC: 11642992. DOI: 10.1371/journal.ppat.1012365.


Elevated levels of butyric acid in the jejunum of an animal model of broiler chickens: from early onset of Clostridium perfringens infection to clinical disease of necrotic enteritis.

Gautam H, Shaik N, Banaganapalli B, Popowich S, Subhasinghe I, Ayalew L J Anim Sci Biotechnol. 2024; 15(1):144.

PMID: 39487547 PMC: 11531110. DOI: 10.1186/s40104-024-01105-5.


Modulating antibody N-glycosylation through feed additives using a multi-tiered approach.

Kranjc J, Kramer L, Mikelj M, Anderluh M, Pislar A, Brinc M Front Bioeng Biotechnol. 2024; 12:1448925.

PMID: 39253702 PMC: 11381414. DOI: 10.3389/fbioe.2024.1448925.


A comparative study of the substrate preference of the sialidases, CpNanI, HpNanH, and BbSia2 towards 2-Aminobenzamide-labeled 3'-Sialyllactose, 6'-Sialyllactose, and Sialyllacto-N-tetraose-b.

Lata M, Ramya T Biochem Biophys Rep. 2024; 39:101791.

PMID: 39156723 PMC: 11326918. DOI: 10.1016/j.bbrep.2024.101791.


The biology and pathogenicity of type F: a common human enteropathogen with a new(ish) name.

Shrestha A, Mehdizadeh Gohari I, Li J, Navarro M, Uzal F, McClane B Microbiol Mol Biol Rev. 2024; 88(3):e0014023.

PMID: 38864615 PMC: 11426027. DOI: 10.1128/mmbr.00140-23.


References
1.
Sillanaukee P, Ponnio M, Jaaskelainen I . Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest. 1999; 29(5):413-25. DOI: 10.1046/j.1365-2362.1999.00485.x. View

2.
Honma K, Mishima E, Sharma A . Role of Tannerella forsythia NanH sialidase in epithelial cell attachment. Infect Immun. 2010; 79(1):393-401. PMC: 3019913. DOI: 10.1128/IAI.00629-10. View

3.
Roggentin P, Kleineidam R, Schauer R . Diversity in the properties of two sialidase isoenzymes produced by Clostridium perfringens spp. Biol Chem Hoppe Seyler. 1995; 376(9):569-75. DOI: 10.1515/bchm3.1995.376.9.569. View

4.
Myers G, Rasko D, Cheung J, Ravel J, Seshadri R, DeBoy R . Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 2006; 16(8):1031-40. PMC: 1524862. DOI: 10.1101/gr.5238106. View

5.
Chiarezza M, Lyras D, Pidot S, Flores-Diaz M, Awad M, Kennedy C . The NanI and NanJ sialidases of Clostridium perfringens are not essential for virulence. Infect Immun. 2009; 77(10):4421-8. PMC: 2747931. DOI: 10.1128/IAI.00548-09. View